Cargando…

Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities

Differentiated thyroid cancers (DTC) are commonly and successfully treated with total thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only treated with surgery but only intrathyroidal tumors are cured. The worst prognosis is for anaplastic (ATC) and poorly diffe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorusso, Loredana, Cappagli, Virginia, Valerio, Laura, Giani, Carlotta, Viola, David, Puleo, Luciana, Gambale, Carla, Minaldi, Elisa, Campopiano, Maria Cristina, Matrone, Antonio, Bottici, Valeria, Agate, Laura, Molinaro, Eleonora, Elisei, Rossella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003273/ https://www.ncbi.nlm.nih.gov/pubmed/33803747 http://dx.doi.org/10.3390/ijms22063117

Ejemplares similares

Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response
por: Campopiano, Maria Cristina, et al.
Publicado: (2023)

Thyroid cancer and COVID-19: experience at one single thyroid disease referral center
por: Prete, Alessandro, et al.
Publicado: (2021)

MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients
por: Valerio, Laura, et al.
Publicado: (2020)

MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children
por: Prete, Alessandro, et al.
Publicado: (2020)

Active Surveillance in RET Gene Carriers Belonging to Families with Multiple Endocrine Neoplasia
por: Prete, Alessandro, et al.
Publicado: (2021)

Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations
por: Elisei, Rossella, et al.
Publicado: (2019)

OR21-01 Pre-Operative Calcitonin Value as a Predictive Factor of Cancer Related Death in Sporadic Medullary Thyroid Carcinoma
por: Matrone, Antonio, et al.
Publicado: (2020)

Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma
por: Minaldi, Elisa, et al.
Publicado: (2023)

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment
por: Viola, David, et al.
Publicado: (2018)

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features
por: Lorusso, L., et al.
Publicado: (2023)

Poorly Differentiated and Anaplastic Thyroid Cancer: Insights into Genomics, Microenvironment and New Drugs
por: Prete, Alessandro, et al.
Publicado: (2021)

Adrenal insufficiency in thyroid cancer patients treated with tyrosine kinase inhibitors and detected by ACTH stimulation test
por: Valerio, L., et al.
Publicado: (2023)

Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma
por: Matrone, Antonio, et al.
Publicado: (2020)

Assessing mPTC Progression during Active Surveillance: Volume or Diameter Increase?
por: Campopiano, Maria Cristina, et al.
Publicado: (2021)

Effect of Pregnancy and Menopause on Micropapillary Thyroid Carcinomas During Active Surveillance
por: Ghirri, Arianna, et al.
Publicado: (2023)

Osteonecrosis of the jaw: a rare but possible side effect in thyroid cancer patients treated with tyrosine-kinase inhibitors and bisphosphonates
por: Lorusso, L., et al.
Publicado: (2021)

Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer
por: Puleo, Luciana, et al.
Publicado: (2022)

Nutrition in Advanced Thyroid Cancer Patients
por: Agate, Laura, et al.
Publicado: (2022)

BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review
por: Matrone, Antonio, et al.
Publicado: (2023)

RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency
por: Ramone, Teresa, et al.
Publicado: (2020)

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer
por: Lorusso, Loredana, et al.
Publicado: (2016)

Clinical, pathological and genetic features of anaplastic and poorly differentiated thyroid cancer: A single institute experience
por: Romei, Cristina, et al.
Publicado: (2018)

MON-524 Prospective Evaluation of Patients with Encapsulated Classical Variant of Papillary Thyroid Cancer and Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): Have They A Similar Prognosis?
por: Giani, Carlotta, et al.
Publicado: (2020)

Usefulness of second (131)I treatment in biochemical persistent differentiated thyroid cancer patients
por: Gambale, Carla, et al.
Publicado: (2023)

Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
por: Matrone, Antonio, et al.
Publicado: (2022)

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing
por: Ciampi, Raffaele, et al.
Publicado: (2019)

RET mutated C-cells proliferate more rapidly than non-mutated neoplastic cells
por: Romei, Cristina, et al.
Publicado: (2021)

Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination
por: Valerio, Laura, et al.
Publicado: (2023)

MON-495 Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma
por: Viola, Nicola, et al.
Publicado: (2020)

Higher RET Gene Expression Levels Do Not Represent anAlternative RET Activation Mechanism in Medullary Thyroid Carcinoma
por: Mulè, Chiara, et al.
Publicado: (2021)

A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion
por: Giani, Carlotta, et al.
Publicado: (2020)

Calcitonin receptor expression in medullary thyroid carcinoma
por: Cappagli, Virginia, et al.
Publicado: (2017)

Core Needle Biopsy Can Early and Precisely Identify Large Thyroid Masses
por: Matrone, Antonio, et al.
Publicado: (2022)

The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy
por: Matrone, Antonio, et al.
Publicado: (2019)

Lenvatinib Administered via Nasogastric Tube in Poorly Differentiated Thyroid Cancer
por: Molinaro, Eleonora, et al.
Publicado: (2019)

Bilateral testicular metastases of medullary thyroid carcinoma in an adult male with multiple endocrine neoplasia 2A syndrome: case report and review of literature
por: Orsolini, Francesca, et al.
Publicado: (2022)

Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
por: Viola, David, et al.
Publicado: (2022)

Differentiated Thyroid Cancer, From Active Surveillance to Advanced Therapy: Toward a Personalized Medicine
por: Matrone, Antonio, et al.
Publicado: (2020)

Clinical–Pathological Features and Treatment Outcome of Patients With Hobnail Variant Papillary Thyroid Carcinoma
por: Poma, Anello Marcello, et al.
Publicado: (2022)

RET/PTC Translocations and Clinico-Pathological Features in Human Papillary Thyroid Carcinoma
por: Romei, Cristina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lvsa10f9rhm93mb79sck5rkcve